RPS6KA3 Antibody, Biotin conjugated

1. Phosphorylation of nuclear YB-1 after stimulation with epidermal growth factor is associated with nuclear accumulation of p90 ribosomal S6 kinase but not of YB-1. PMID: 30126195
2. Data show that phosphorylation of ribosomal protein S6 kinase 2 (RSK2) at threonine 577 is essential for leukemia-associated RhoGEF (LARG)-dependent Rho GTPase activation. PMID: 29279389
3. Phosphorylation of T-bet by RSK2 is required for IFNgamma expression for attenuation of colon cancer metastasis and growth. PMID: 29133416
4. Strong evidence that RSK inhibitors could enhance the effectiveness of existing Glioblastoma (GBM) treatment, and support RSK2 targeting as a promising approach for novel GBM therapy. PMID: 27829215
5. RSK2 affects mitotic progression by regulating the distribution, basal level and the stability of mitotic spindles. PMID: 27491410
6. Osajin binds with RSK2 directly in an ATP-competitive manner. Computer modeling simulated a plausible binding orientation between osajin and RSK2. Osajin inhibited sUV-induced phosphorylation of histone H3, a substrate of RSK2. PMID: 28409880
7. TLR4 and C5aR crosstalk in dendritic cells induces a core regulatory network of RSK2, PI3Kbeta, SGK1, and FOXO transcription factors. PMID: 28733463
8. The mTOR pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast cancer risk (P = 0.003 and 0.03, respectively). PRKAG3 (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively. PMID: 28582508
9. Inhibition of RSK2 was used to investigate the function of RSK2 on PDK1-induced inflammation. The phosphorylation of RSK2 was detected when PDK1 was inhibited. Inhibition of RSK2 reduced the PDK1-induced cell invasion and cytokines secretion in human rheumatoid arthritis synovial MH7A cells. In response to TNF-alpha, PDK1 could phosphorylate RSK2 and activated RSK2, then promoting the activation of NF-kappaB. PMID: 28314444
10. Our finding demonstrates that RSK2 directly phosphorylates stathmin and regulates microtubule polymerization to provide a pro-invasive and pro-metastatic advantage to cancer cells. Therefore, the RSK2-stathmin pathway represents a promising therapeutic target and a prognostic marker for metastatic human cancers. PMID: 27041561
11. we discuss the function of the RSK2 signaling axis by interactions with binding partners in cancer development--{REVIEW} PMID: 28013489
12. Results showed that RSK2 gene was overexpressed in osteosarcoma patients cells and its knockdown increased cell apoptosis, enhanced cell chemosensitivity, inhibits proliferation and migration, and weakened tumor formation. PMID: 27082640
13. Upregulated expression of RSK2 is associated with breast cancer. PMID: 27476168
14. This case is one of the few examples where RPS6KA3 mutations are associated with a non-specific X-linked mental retardation. PMID: 26354035
15. miR-191 represses proliferation in primary human fibroblasts via targeting multiple proto-oncogenes, including CDK9, NOTCH2, and RPS6KA3. PMID: 25992613
16. This is the first report of exon skipping from an exonic mutation of RPS6KA3, demonstrating that a missense mutation and concomitant disruption of normal splicing contribute to the manifestation of CLS PMID: 26297997
17. Rsk2-mediated inhibition of hyperplasia has now been demonstrated to occur in the arthritic synovium. PMID: 25624005
18. Study identifies RSK2 as a new kinase that regulates NHE3 activity by direct phosphorylation. PMID: 25855080
19. RPS6KA3 in three unrelated Coffin-Lowry syndrome patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations, were analyzed. PMID: 25044551
20. Activated RSK2 directly interacts with and phosphorylates FGFR1, thereby modulating receptor signaling through regulation of endocytosis. PMID: 24141780
21. 14-3-3 binding promotes PDCD4 degradation, suggesting an important role for RSK in the inactivation of PDCD4 in melanoma. PMID: 25002506
22. Kaposi's sarcoma-associated herpesvirus ORF45 mediates activation of the HIV-1 long terminal repeat via RSK2. PMID: 24719417
23. our results identify the integrin-RSK signaling axis as an important regulator of cytokinesis in epithelial cells PMID: 24284076
24. This report also suggests that there is no genotype-phenotype correlation between the location and type of RPS6KA3 gene mutations and SIDEs. PMID: 24311527
25. RSK2 regulates craniofacial development including tooth development and patterning via novel transcriptional targets PMID: 24416220
26. findings demonstrated that RSK2 plays an important role in the DNA damage pathway that maintains genomic stability by mediating cell cycle progression and DNA repair PMID: 24086335
27. protein effectors of the RSK2-CREB-Fascin-1 pathway represent promising biomarkers and therapeutic targets in the clinical prognosis and treatment of metastatic human cancers. PMID: 24085294
28. Data indicate that the N-terminal kinase domain of p90 ribosomal S6 kinase, isoform 2, binds three different flavonol rhamnosides in a highly unusual manner, distinct from other kinase inhibitor interactions. PMID: 23541530
29. RSK2 functions as a signal integrator to provide antianoikis protection to cancer cells in both transcription-independent and -dependent manners, in part by signaling through ASK1 and CREB, and contributes to cancer cell invasion and tumor metastasis. PMID: 23608533
30. ILKAP is a nuclear protein that regulates cell survival and apoptosis through the regulation of RSK2 signaling. PMID: 23329845
31. Results indicate that RSK2 is regulated in response to cisplatin treatment, and this downregulation may contribute to the cytotoxic action of cisplatin. PMID: 23041051
32. RSK2 plays a key role in neoplastic transformation of human skin cells and in skin cancer growth. PMID: 22918890
33. These results reveal RSK2 as a key regulator of integrin activity and provide a novel mechanism by which it may promote cell migration and cancer metastasis. PMID: 23118220
34. Epidermal growth factor (EGF) induces ribosomal S6 kinase 2 (RSK2) ubiquitination, and knocking down TRAF2 suppresses ubiquitination of RSK2 induced by EGF PMID: 22685297
35. To our knowledge, this is the first family identified with a submicroscopic duplication including the entire RPS6KA3/RSK2 gene, and our findings suggest that an increased dose of this gene is responsible for a mild form of NS-XLID. PMID: 21930553
36. MSP-induced RSK2 activation is a critical determinant linking RON signaling to cellular EMT program. PMID: 21619683
37. data provide a direct link between RSK2 and caspase-8 and identify a novel molecular mechanism for caspase-8 modulation by RSK2 PMID: 21183680
38. RSK2 could regulate neurotransmitter release by activating phospholipase D production of lipids required for exocytosis. PMID: 21061166
39. Data show that RSK2 is activated by treatment with tumor necrosis factor-alpha (TNF-alpha) and directly phosphorylates IkappaBalpha at Ser-32, leading to IkappaBalpha degradation. PMID: 20385620
40. the involvement of Rsk2 in the activation and maintenance of the spindle assembly checkpoint in metaphase II-arrested Xenopus egg extracts and in human cells PMID: 20383198
41. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. PMID: 20234090
42. Data identify a novel reciprocal regulation of Tat and RSK2 function, which might serve to induce early changes in the chromatin organization of the HIV LTR. PMID: 17225856
43. Mutations cause X-linked Coffin-Lowry Syndrome, a mental retardation syndrome. PMID: 11896450
44. Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome PMID: 11992250
45. Molecular crosstalk between p70S6k and MAPK cell signaling pathways PMID: 12054624
46. This protein is mutated in ataxia telangiectasia and is involved in the phoshphorylation of STAT3. PMID: 12562765
47. Postmortem fundings in the CLS syndrome are presented. PMID: 12792428
48. activity is regulated by interaction with PEA-15 PMID: 12796492
49. Expression pattern during development suggests it may be involved in cognitive impairment and facial dysmorphisms found in Coffin-Lowry Syndrome. PMID: 14678837
50. Investigation of the mechanisms underlying aberrant splicing of RSK2 mRNA. PMID: 14973203

显示更多

收起更多

HGNC: 10432

OMIM: 300075

KEGG: hsa:6197

STRING: 9606.ENSP00000368884

UniGene: Hs.445387